Back to search

Article

PD-1 Inhibitor Plus Chemotherapy Versus Chemotherapy for First-Line Treatment in Advanced Esophageal Cancer: A Systematic Review and Meta-Analysis.

2021-10-06

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Immunotherapy combined with chemotherapy has recently changed the first-line treatment of several cancers. We perform a systematic meta-analysis to assess the efficacy and safety of PD-1 inhibitor plus chemotherapy for first-line treatment in advanced esophageal cancer.<bold>Methods: </bold>Data were collected from eligible studies searched from PubMed, Web of S...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2990123e-e1fc-5eb8-9b9c-47e1259997a8
DOI
10.21203/rs.3.rs-952464/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
PD-1 Inhibitor Plus Chemotherapy Versus Chemotherapy for First-Line Treatment in Advanced Esophageal Cancer: A Systematic Review and Meta-Analysis.DOI 10.21203/rs.3.rs-952464/v1
Immunotherapy Combined with Chemotherapy versus Chemotherapy Alone in Advanced Pancreatic Ductal Adenocarcinoma: a Real-world Retrospective Cohort StudySemantic proximity
Comparative Analysis of Clinical Outcomes Between Neoadjuvant Chemoimmunotherapy and Neoadjuvant Chemoradiotherapy in Patients with Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter, Retrospective StudySemantic proximity
Efficacy and Safety of PD-1/PD-L1 plus CTLA-4 antibodies +/− Other Therapies in Lung Cancer: A Systematic Review and Meta-AnalysisSemantic proximity
Immune Checkpoint Inhibitor without Pemetrexed for First-line Maintenance Therapy in Advanced Lung Adenocarcinoma: A real-world retrospective studySemantic proximity
Toxicities of PD-1/PD-L1 Inhibitors: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsSemantic proximity
Efficacy of First-Third generation EGFR inhibitor combined with chemotherapy as first-line treatment for advanced lung adenocarcinoma in a real-world settingSemantic proximity
Comparison of Neoadjuvant Chemoimmunotherapy and Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma: A Retrospective Study with 3-Year Survival AnalysisSemantic proximity
Efficacy and safety of immune checkpoint inhibitors versus chemotherapy in advanced non-small cell lung cancer: A systematic review of randomized controlled trialsSemantic proximity
Association of the CD4+ /CD8+ ratio with response to PD-1 inhibitor-based combination therapy and dermatologic toxicities in patients with advanced gastric and esophageal cancerSemantic proximity
Treatment patterns and Outcomes of Elderly Patients with Potentially Curable Esophageal CancerSemantic proximity
Systematic review and meta-analysis on targeted therapy in advanced pancreatic cancer.Semantic proximity
Comparative Safety of Immune Checkpoint Inhibitors and Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-AnalysisSemantic proximity
Select a neighboring publication to make it the new centre.